€€€€€€ Die Neue Novavax€€€€€€ - 500 Beiträge pro Seite

[Kaufmonster]

Die Neue Novavax

startet gerade an der Nasdaq

Seit diesmal von Anfang an dabei, der Hype beginnt

[Roulett.Profi]

AVAN (NASDAQ NM)

--------------------------------------------------------------------------------
bellwetherreport.com: The Bellwether Report continues to follow AVANT Immunotherapeutics Inc

MONDAY , NOVEMBER 14, 2005 12:51 PM


Nov 14, 2005 (M2 PRESSWIRE via COMTEX) -- Today the Bellwether Report has identified AVANT Immunotherapeutics
Inc. (NASDAQ:AVAN), a company that our analysts will be tracking over
the ensuing weeks. They recently came out with a significant corporate
development this month, causing a positive correction. For a full
report on the below mentioned company, and many more, feel free to
visit www.bellwetherreport.com for a free 30 day no obligation trial.




Early this morning AVANT announced that it has formed a research team
to focus on development of an avian flu vaccine utilizing in part
AVANT`s proprietary bacterial vectoring technologies and VitriLife
preservation processes.




"The combination of conserved antigens together with our existing
vaccine technologies could lead to an avian flu vaccine with product
characteristics ideal for mass vaccinations: safe and effective,
single-dose, oral, storable at room temperature," said Una S. Ryan,
Ph.D., AVANT`s President and Chief Executive Officer. "We are
dedicating resources today to pursue this challenge, however, an
effective response to pandemic flu requires the involvement of many
parties - governments, international organizations and vaccine
manufacturers," she continued.




A few weeks ago the company announced their third quarter results.
Revenues during the third quarter of 2005 were $846,322 compared to
revenues of $527,510 for the same period last year. Total operating
expenses for the quarter were $5.5 million compared to $4.3 million in
the same quarter last year. The Company`s research and development
expenses for the three-month period ended September 30, 2005 were $3.6
million compared to $2.8 million for the same period last year.




The increase in research and development.....




To view the full unbiased report on AVANT Immunotherapeutics Inc.
(NASDAQ:AVAN), feel free to visit our site. This article and many more
are available for review under the Today`s Articles Section. No credit
Card Needed!!




The Bellwether Report will continue scanning the markets for true
emerging growth opportunities that will show subscribers optimal entry
points with profitable exit points. If you are interested in receiving
more information on feel free to sign up for a 1 month complimentary
subscription to the #1 online investment resource
www.bellwetherreport.com.




All material herein was prepared by the Bellwetherreport.com,
(Bellwether) based upon information believed to be reliable. The
information contained herein is not guaranteed by Bellwether to be
accurate, and should not be considered to be all-inclusive. The
companies that are discussed in this opinion have not approved the
statements made in this opinion. This opinion contains forward-looking
statements that involve risks and uncertainties. This material is for
informational purposes only and should not be construed as an offer or
solicitation of an offer to buy or sell securities. Bellwether is not a
licensed broker, broker dealer, market maker, investment banker,
investment advisor, analyst or underwriter. Please consult a broker
before purchasing or selling any securities viewed on or mentioned
herein. Bellwether may receive compensation in cash or shares from
independent third parties or from the companies mentioned.




Bellwether`s affiliates, officers, directors and employees may also
have bought or may buy the shares discussed in this opinion and may
profit in the event those shares rise in value. Market commentary
provided by Jay Lee.




Bellwether will not advise as to when it decides to sell and does not
and will not offer any opinion as to when others should sell; each
investor must make that decision based on his or her judgment of the
market.




This release contains "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section
21E the Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may", "future", "plan" or "planned", "will" or "should", "expected,"
"anticipates", "draft", "eventually" or "projected". You are cautioned
that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results
to differ materially from those projected in the forward-looking
statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a companies`
annual report on Form 10-K or 10-KSB and other filings made by such
company with the Securities and Exchange Commission.




You should consider these factors in evaluating the forward-looking
statements included herein, and not place undue reliance on such
statements. The forward-looking statements in this release are made as
of the date hereof and Bellwether undertakes no obligation to update
such statements.




M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
[e-mail].

[Boersenfuchs69]

Tageshoch an der Nasdaq

Die zweite Novavax rollt los

[PizPalue]

[posting]18.791.479 von Boersenfuchs69 am 14.11.05 20:09:09[/posting]Neuemission?

[kgv1]

BULLSHIT, der neue Novavax, heisst auch Novavax Kursziel 18U$D
Oder evtl. auch ein CBMX packed to go, ihr Avant Tageszocker, schämt Euch.
Kgv1

[Boersenfuchs69]

Der war gut
Taschengeldzocker
Na dann pass mal auf das AVAN nicht bald vorbeispurtet an Deiner 18$ Novavax

Abwarten, morgen gehts weiter